Discontinued Operations (Details Narrative) - USD ($) |
May 28, 2025 |
Mar. 31, 2026 |
Dec. 31, 2025 |
Jun. 01, 2025 |
|---|---|---|---|---|
| Restructuring Cost and Reserve [Line Items] | ||||
| Common stock shares | 1,640,635 | 477,366 | ||
| NAYA Therapeutics Inc [Member] | ||||
| Restructuring Cost and Reserve [Line Items] | ||||
| Common stock shares | $ 4,803,175 | |||
| NAYA Therapeutics Inc [Member] | ||||
| Restructuring Cost and Reserve [Line Items] | ||||
| Common stock shares | 3,227,813 | |||
| Preferred stock shares | 6,300 | |||
| Interest rate | 7.00% |
| X | ||||||||||
- Definition Amount of consideration transferred in asset acquisition. Includes, but is not limited to, cash, liability incurred by acquirer, and equity interest issued by acquirer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Contractual interest rate for funds borrowed, under the debt agreement. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|